-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Structure Therapeutics, Raises Price Target to $114

Benzinga·03/02/2026 13:45:52
Listen to the news
HC Wainwright & Co. analyst Ananda Ghosh maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and raises the price target from $90 to $114.